Trial Profile
A phase II study of systemic chemotherapy with TS-1 and CDDP followed by surgery in advanced gastric cancer with extensive lymph node metastasis(JCOG0405)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2018
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Jan 2018 Results assessing histopathological tumor regression or ypN as a predictor of response in patients from JCOG0001, JCOG0405, JCOG0210 trials (n=85) presented at the 2018 Gastrointestinal Cancers Symposium
- 02 Jul 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2009 New trial record.